Gold rises past $5,000 for the first time as global tensions deepen
Gold broke above US$5,000 per ounce for the first time, extending a historic rally driven by escalating geopolitical and economic uncertainty.
Market Open: Abbott Misses Revenue Estimates, Lucid Surges on Saudi Deal | Jan 22
TSX rises as Abbott falls on weak diagnostics and Lucid jumps 18% on Saudi production deal. Oil gains, gold eases, and Bitcoin slips.
NATO under pressure – Is silver the new gold? Dream returns with Silver North, fresh momentum for Rheinmetall and TKMS
Geopolitical upheavals are exposing deep rifts of trust between the superpowers. The US approach toward Greenland...
A custom portable drill advancing exploration in Labrador
Viridian Metals (CSE:VRDN) is now drilling its high-grade Kraken copper, nickel and cobalt project in Labrador.
Market Open: Netflix Plunges on Guidance, Cenovus Eyes $3B Asset Sale | Jan 21
TSX falls as Netflix drops 5% on soft guidance and Cenovus considers selling Alberta assets. Gold hits record highs; natural gas surges nearly 19%.
Market Open: 3M Stock Sinks on Earnings, Big Tech Retreats Amid Tariff Fears | Jan 20
TSX edges higher as 3M stock drops and Big Tech retreats amid tariff concerns. Gold surges past $4,700; natural gas spikes over 10%.
A clean technology company on the verge of transformational growth
Birchtech (TSX:BCHT) is a clean air and clean water technology specialist rising to the task of mitigating mercury and PFAS emissions.
Market Open: Netflix Holds Steady Before Earnings, Inflation Climbs to 2.4% | Jan 19
TSX edges higher as Netflix steadies before earnings and Canadian inflation rebounds to 2.4%. Gold jumps, oil rises, and natural gas surges.
Armored steel meets swarm intelligence: Why Rheinmetall and Hensoldt must retool – and why NEO Battery Materials could become a hidden winner of the drone war
The war in Ukraine has shattered military doctrines that were considered irrefutable in NATO headquarters for...
An immunotherapy value play advancing the fight against bladder cancer
An in-depth look at BioVaxys Technology (CSE:BIOV), a micro-cap stock combining a promising drug pipeline with irrational investor pessimism.